Electra Therapeutics, Inc (ETRA) Stock
Key stats
- Market cap
- $593.15M
- Price / Earnings ratio
- -7.9x
- EPS (TTM)
- -$1408.52
- Volume
- Loading
- 52-week high
- $15.50
- 52-week low
- $6.87
Source: third-party data provider, as of November 13, 2026
Compare with ETRA
Recent news

Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
ETRA

Electra Therapeutics targets $977.6 million valuation in US IPO
Electra Therapeutics targets $977.6 million valuation in US IPO
ETRA
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 52.41
- MACD 12/26/9
- -0.62
- EMA 9 of MACD
- -0.84
- MACD histogram
- 0.22
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
ETRA

Electra Therapeutics targets $977.6 million valuation in US IPO
Electra Therapeutics targets $977.6 million valuation in US IPO
ETRA
News tone: automated (AI) classification of the article's content, not a price prediction.
About Electra Therapeutics, Inc
The company is a late clinical-stage biopharmaceutical firm focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Quehuong Dong M.B.A., Pharm.D. | President, CEO & Director | 1982 |
| Mr. Christopher W. Clark C.F.A. | Chief Financial Officer | 1978 |
| Mr. Gary S. Koe Ph.D. | Chief Technology Officer | 1964 |
| Dr. Kim-Hien Dao D.O., Ph.D. | Chief Medical Officer | 1973 |
| Dr. Graham Parry Ph.D. | Chief Scientific Officer | 1964 |
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 52.41
- MACD 12/26/9
- -0.62
- EMA 9 of MACD
- -0.84
- MACD histogram
- 0.22
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $30.00
- Average
- $32.67
- High
- $36.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.1 | -24.2 | +29.3 |



